Effect of osteopenia and osteoporosis on failure of first and second dental implants: a retrospective observational study.
Endosseous dental implants
Implant failure
Implant survival
Osseointegration
Osteoporosis
Re-implantation
Journal
International journal of implant dentistry
ISSN: 2198-4034
Titre abrégé: Int J Implant Dent
Pays: Germany
ID NLM: 101676532
Informations de publication
Date de publication:
04 Sep 2024
04 Sep 2024
Historique:
received:
17
07
2023
accepted:
18
07
2024
medline:
4
9
2024
pubmed:
4
9
2024
entrez:
4
9
2024
Statut:
epublish
Résumé
The present study evaluated osteopenia (OPN) and osteoporosis (OP) as risk factors for dental implant failure and repeat failure. We performed a retrospective study on over 100 randomly selected patients per analysis to determine the effect of health status, smoking status, sex, implant location and operative conditions on first and second (re-implantation) implant survival. Analyses were conducted first using chi-squared test, followed by multiple logistic regression for significant variables. In the cohort examining the effect of myriad risk factors on second implant survival, it was found that OPN and OP greatly impacted implant survival, wherein patients with osteoporosis or osteopenia had significantly more implant failures (p = 0.0353). Sex and operative conditions had no effect on implant survival, while implant location showed a notable effect wherein significantly more failures occurred in the maxilla vs mandible (p = 0.0299). Upon finding that OPN and OP have a significant effect on second implant survival, we conducted an additional study focusing on the impact of health status. Based on the multiple logistical regression analysis, we found that OPN and OP are the most significant factor in first implant survival (p = 0.0065), followed by diabetes (p = 0.0297). Importantly, it was observed that early implant failure is also significantly correlated with osteoporosis (p = 0.0044). We show here a marked relationship in which the risk of first and second implant failure are significantly higher in patients with osteoporosis and osteopenia.
Identifiants
pubmed: 39230775
doi: 10.1186/s40729-024-00556-9
pii: 10.1186/s40729-024-00556-9
doi:
Substances chimiques
Dental Implants
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
40Informations de copyright
© 2024. The Author(s).
Références
Karoussis IK, Kotsovilis S, Fourmousis I. A comprehensive and critical review of dental implant prognosis in periodontally compromised partially edentulous patients. Clin Oral Implants Res. 2007;18:669–79.
pubmed: 17868376
doi: 10.1111/j.1600-0501.2007.01406.x
Renvert S, Aghazadeh A, Hallstrom H, Persson GR. Factors related to peri-implantitis—a retrospective study. Clin Oral Implants Res. 2014;25:522–9.
pubmed: 23772670
doi: 10.1111/clr.12208
Takamiya AS, Goiato MC, Gennari Filho H. Effect of smoking on the survival of dental implants. Biomed Pap. 2014. https://doi.org/10.5507/bp.2013.037 .
doi: 10.5507/bp.2013.037
Clementini M, et al. Systemic risk factors for peri-implant bone loss: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2014;43:323–34.
pubmed: 24373525
doi: 10.1016/j.ijom.2013.11.012
Daubert DM, Weinstein BF, Bordin S, Leroux BG, Flemming TF. Prevalence and predictive factors for peri-implant disease and implant failure: a cross-sectional analysis. J Periodontol. 2015;86:337–47.
pubmed: 25415249
doi: 10.1902/jop.2014.140438
Misch K, Wang H-L. Implant surgery complications: etiology and treatment. Implant Dent. 2008;17:159–68.
pubmed: 18545047
doi: 10.1097/ID.0b013e3181752f61
Steigenga JT, Al-Shammari KF, Nociti FH, Misch CE, Wang H-L. Dental implant design and its relationship to long-term implant success. Implant Dent. 2003;12:306–17.
pubmed: 14752967
doi: 10.1097/01.ID.0000091140.76130.A1
Oh S-L, Shiau HJ, Reynolds MA. Survival of dental implants at sites after implant failure: a systematic review. J Prosthet Dent. 2020;123:54–60.
pubmed: 31027959
doi: 10.1016/j.prosdent.2018.11.007
Kang D-W, Kim S-H, Choi Y-H, Kim Y-K. Repeated failure of implants at the same site: a retrospective clinical study. Maxillofac Plast Reconstr Surg. 2019;41:1–9.
doi: 10.1186/s40902-019-0209-1
Romandini M, et al. Long-term outcomes and prognostic factors of surgical treatment of peri-implantitis–A retrospective study. Clin Oral Implants Res. 2023. https://doi.org/10.1111/clr.14228 .
doi: 10.1111/clr.14228
pubmed: 38112108
Kumar PS. Systemic risk factors for the development of periimplant diseases. Implant Dent. 2019;28:115–9.
pubmed: 30893143
doi: 10.1097/ID.0000000000000873
Chen H, Liu N, Xu X, Qu X, Lu E. Smoking, radiotherapy, diabetes and osteoporosis as risk factors for dental implant failure: a meta-analysis. PLoS ONE. 2013;8:e71955.
pubmed: 23940794
pmcid: 3733795
doi: 10.1371/journal.pone.0071955
Wagner J, Spille JH, Wiltfang J, Naujokat H. Systematic review on diabetes mellitus and dental implants: an update. Int J Implant Dent. 2022;8:1–21.
pubmed: 34978649
pmcid: 8724342
doi: 10.1186/s40729-021-00399-8
Marchand F, et al. Dental implants and diabetes: conditions for success. Diabetes Metab. 2012;38:14–9.
pubmed: 22284547
doi: 10.1016/j.diabet.2011.10.002
Al Ansari Y, Shahwan H, Chrcanovic BR. Diabetes mellitus and dental implants: a systematic review and meta-analysis. Materials. 2022;15:3227.
pubmed: 35591561
pmcid: 9105616
doi: 10.3390/ma15093227
Winer N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol. 2004;44:397–405.
pubmed: 15051748
doi: 10.1177/0091270004263017
C. f. D. Control, Prevention, Increasing prevalence of diagnosed diabetes--United States and Puerto Rico, 1995-2010. MMWR. Morbidity and mortality weekly report 61, 918-921 (2012).
Becker W, Hujoel PP, Becker BE, Willingham H. Osteoporosis and implant failure: an exploratory case-control study. J Periodontol. 2000;71:625–31.
pubmed: 10807128
doi: 10.1902/jop.2000.71.4.625
Alqutaibi AY, Radi IA-E. No clear evidence regarding the effect of osteoporosis on dental implant failure. J Evid Based Dental Pract. 2016;16:124–6.
doi: 10.1016/j.jebdp.2016.06.002
Giro G, et al. Impact of osteoporosis in dental implants: a systematic review. World J Orthop. 2015;6:311.
pubmed: 25793172
pmcid: 4363814
doi: 10.5312/wjo.v6.i2.311
Karaguzel G, Holick MF. Diagnosis and treatment of osteopenia. Rev Endocr Metab Disorders. 2010;11:237–51.
doi: 10.1007/s11154-010-9154-0
Lorentzon M, Cummings SR. Osteoporosis: the evolution of a diagnosis. J Intern Med. 2015;277:650–61.
pubmed: 25832448
doi: 10.1111/joim.12369
Modagan P, Silambanan S, Menon PG, Arunalatha P. Comparison of bone mineral density with biochemical parameters and prevalence of osteopenia and osteoporosis in South Indian population. Biomed Pharmacol J. 2018;11:2209–14.
doi: 10.13005/bpj/1603
Yong E-L, Logan S. Menopausal osteoporosis: screening, prevention and treatment. Singap Med J. 2021;62:159.
doi: 10.11622/smedj.2021036
Christodoulou C, Cooper C. What is osteoporosis? Postgrad Med J. 2003;79:133–8.
pubmed: 12697910
pmcid: 1742639
doi: 10.1136/pmj.79.929.133
Li L, Wang Z. Ovarian aging and osteoporosis. In: Wang Z, editor. Aging and aging-related diseases: mechanisms and interventions. Singapore: Springer; 2018. p. 199–215.
doi: 10.1007/978-981-13-1117-8_13
Choi MH, Yang JH, Seo JS, Kim Y-J, Kang S-W. Prevalence and diagnosis experience of osteoporosis in postmenopausal women over 50: focusing on socioeconomic factors. PLoS ONE. 2021;16:e0248020.
pubmed: 33651848
pmcid: 7924764
doi: 10.1371/journal.pone.0248020
Sözen T, Özışık L, Başaran NÇ. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4:46.
pubmed: 28293453
doi: 10.5152/eurjrheum.2016.048
Heufelder MJ, et al. Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw. Oral Surg, Oral Med, Oral Pathol Oral Radiol. 2014;117:e429–35.
pubmed: 23182374
doi: 10.1016/j.oooo.2012.08.442
Kwon TG, et al. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin Oral Implants Res. 2014;25:632–40.
pubmed: 23278625
doi: 10.1111/clr.12088
Everts-Graber J, et al. Risk of osteonecrosis of the jaw under denosumab compared to bisphosphonates in patients with osteoporosis. J Bone Miner Res. 2022;37:340–8.
pubmed: 34787342
doi: 10.1002/jbmr.4472
Watts NB, et al. Invasive oral procedures and events in postmenopausal women with osteoporosis treated with denosumab for up to 10 years. J Clin Endocrinol Metab. 2019;104:2443–52.
pubmed: 30759221
doi: 10.1210/jc.2018-01965
Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397–410.
pubmed: 18022461
doi: 10.1016/j.joms.2007.08.003
Hellstein JW, et al. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American dental association council on scientific affairs. J Am Dental Assoc. 2011;142:1243–51.
doi: 10.14219/jada.archive.2011.0108
French D, Ofec R, Levin L. Long term clinical performance of 10 871 dental implants with up to 22 years of follow-up: a cohort study in 4247 patients. Clin Implant Dent Related Res. 2021;23:289–97.
doi: 10.1111/cid.12994
Setzer F, Kim S. Comparison of long-term survival of implants and endodontically treated teeth. J Dental Res. 2014;93:19–26.
doi: 10.1177/0022034513504782
Jemt T. Implant failures and age at the time of surgery: a retrospective study on implant treatments in 4585 edentulous jaws. Clin Implant Dent Related Res. 2019;21:514–20.
doi: 10.1111/cid.12753
Ikebe K, Wada M, Kagawa R, Maeda Y. Is old age a risk factor for dental implants? Jpn Dental Sci Rev. 2009;45:59–64.
doi: 10.1016/j.jdsr.2009.02.001
De Medeiros F, et al. Dental implants in patients with osteoporosis: a systematic review with meta-analysis. Int J Oral Maxillofac Surg. 2018;47:480–91.
pubmed: 28651805
doi: 10.1016/j.ijom.2017.05.021
P. K. Moy, D. Medina, V. Shetty, T. L. Aghaloo, Dental implant failure rates and associated risk factors. International Journal of Oral & Maxillofacial Implants 20 (2005).
Saito M, Marumo K. Bone quality in diabetes. Front Endocrinol. 2013;4:72.
doi: 10.3389/fendo.2013.00072
Saito M, Kida Y, Kato S, Marumo K. Diabetes, collagen, and bone quality. Curr Osteoporos Rep. 2014;12:181–8.
pubmed: 24623537
doi: 10.1007/s11914-014-0202-7
Chrcanovic BR, Albrektsson T, Wennerberg A. Bone quality and quantity and dental implant failure: a systematic review and meta-analysis. Int J Prosthodont. 2017. https://doi.org/10.1160/ijp.5142 .
doi: 10.1160/ijp.5142
pubmed: 28806425
Smith RWJR, Eyler WR, Mellinger RC. On the incidence of senile osteoporosis. Ann Intern Med. 1960;52:773–81.
pubmed: 13832149
doi: 10.7326/0003-4819-52-4-773
N. Sarafrazi, E. A. Wambogo, J. A. Shepherd, Osteoporosis or low bone mass in older adults: United States, 2017–2018. (2021).
Mohajerani H, Roozbayani R, Taherian S, Tabrizi R. The risk factors in early failure of dental implants: a retrospective study. J Dent. 2017;18:298.
Park WB, Kang KL, Han JY. Factors influencing long-term survival rates of implants placed simultaneously with lateral maxillary sinus floor augmentation: a 6-to 20-year retrospective study. Clin Oral Implants Res. 2019;30:977–88.
pubmed: 31306519
doi: 10.1111/clr.13505
Holahan CM, et al. Effect of osteoporotic status on the survival of titanium dental implants. Int J Oral Maxillofac Implants. 2008;23:905–10.
pubmed: 19014161
Belibasakis GN, Bostanci N. The RANKL-OPG system in clinical periodontology. J Clin Periodontol. 2012;39:239–48.
pubmed: 22092994
doi: 10.1111/j.1600-051X.2011.01810.x
Weitzmann MN. The role of inflammatory cytokines, the RANKL/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis. Scientifica. 2013. https://doi.org/10.1155/2013/125705 .
doi: 10.1155/2013/125705
pubmed: 24278766
pmcid: 3820310
Marie P, Halbout P. OPG/RANKL: role and therapeutic target in osteoporosis. Med Sci: M/S. 2008;24:105–10.